![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 46, 35680-35683, November 17, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Microbiology and Molecular Genetics,
Harvard Medical School, Molecular Medicine Unit, Beth Israel
Deaconess Medical Center, Boston, Massachessetts 02215
Received for publication, September 13, 2000
Protein phosphatase-2A (PP2A) is a multisubunit
serine/threonine phosphatase involved in intracellular signaling, gene
regulation, and cell cycle progression. Different subunits of PP2A bind
to Axin and Adenomatous Polyposis Coli, components of the
Wnt signal transduction pathway. Using early Xenopus
embryos, we studied how PP2A functions in Wnt signal transduction. The
catalytic subunit of PP2A (PP2A-C) potentiated secondary axis induction
and Siamois reporter gene activation by Dishevelled, a
component of the Wnt pathway, indicating a positive regulatory role of
this enzyme in Wnt signaling. In contrast, small t antigen, an
antagonist of PP2A-C, inhibited Dishevelled-mediated signal
transduction, as did the regulatory PP2A-B' The Wnt family of secreted glycoproteins regulates many biological
processes including cell growth, cell polarity, and tissue specification (1-3). In Xenopus embryos, microinjection of
RNAs encoding certain Wnts into ventral-vegetal blastomeres leads to generation of a secondary dorsal-ventral axis (4). Furthermore, inhibition of downstream Wnt signaling suppresses the formation of the
primary axis (5, 6). Thus, activation of the Wnt pathway plays a key
role in dorsal axis development in vertebrates.
Genetic and biochemical approaches have identified many components of
the Wingless/Wnt signal transduction pathway. Wnts bind to
transmembrane Frizzled receptors, which leads to activation of the
cytoplasmic Dsh (Dishevelled) protein
(7, 8). Dsh forms a complex with proteins of the Axin family (9-12),
which also bind glycogen synthase kinase-3 The biochemical mechanism by which the
Axin·GSK-3·APC· We have used microinjection assays in Xenopus laevis to
probe the action of PP2A in Wnt signaling. We show that PP2A-C is a
necessary positive component of Wnt signaling in Xenopus.
Unexpectedly, we find that PP2A can act downstream or parallel to
DNA Constructs--
The Siamois-luciferase reporter
construct (pSia-Luc) (29), pE1b-luciferase (30), dominant negative
GSK-3 (DN-GSK-3) (31), and the hemagglutinin-tagged form of
Xenopus Dsh (Xdsh) (12) have been described
previously. For synthesis of mRNA for injection experiments, bovine
PP2A-C Xenopus Embryos, Microinjections, and Luciferase
Assays--
These were performed as described previously (34).
Luciferase activity data are presented as the average of triplicate
samples, each comprising five embryos, and every experiment was
reproduced on at least three separate occasions. The following amounts
of RNA were injected: Xdsh, 500 or 125 pg as indicated; PP2A-B' Protein Analysis--
For PP2A Is an Essential Positive Regulator of the Wnt
Pathway--
The role of PP2A in Wnt signaling was studied using RNA
microinjection assays in early frog embryos. Dsh is an essential
component of the Wnt pathway and, when overexpressed, induces an
ectopic secondary axis (37, 38). mRNA encoding the catalytic
subunit of bovine PP2A (PP2A-C
We also studied transcriptional activation of a reporter gene
comprising the promoter for the Wnt target Siamois linked to luciferase (pSia-Luc) (27). This construct was coinjected with Xdsh
mRNA into Xenopus ventral animal blastomeres at the
4-8-cell stage. Embryos were harvested at stage 10.5, and luciferase
activity was assayed. This site of injection was chosen, because the
pSia-Luc reporter alone is not significantly induced in ventral animal blastomeres (29). The reporter activity was up-regulated by Xdsh, and
this activation was further increased by PP2A-C
SV40 small t antigen (Smt) is a commonly used inhibitor of the
catalytic subunit of PP2A (39). Overexpression of Smt completely blocked the ability of Xdsh to activate pSia-Luc (Fig. 2B).
An E1b-luciferase promoter was used as a control to confirm that this
decrease in signal from pSia-Luc was not because of nonspecific inhibition of basal transcription or translation in response to Smt. In
fact, there was a slight increase in signal from the E1b-luciferase reporter (Fig. 2B) and a cytomegalovirus-luciferase
reporter (data not shown) in the presence of Smt, suggesting that
PP2A-C has a negative influence on transcription and/or translation.
These data indicate that PP2A-C function is required for Wnt signal transduction.
The PP2A-B' PP2A-C Acts Independently of
The inability of PP2A-C or Smt to affect
Recent evidence has shown that Wnt signaling can be regulated at the
level of Tcfs (44). Although XTcf-3 is required for transmission of the
Wnt signal, when injected alone it is unable to induce transcription of
dorsal-specific genes and instead acts as a repressor (19, 45).
Consistent with these reports, we found that XTcf-3 mRNA was unable
to induce pSia-Luc reporter activity when injected into animal-ventral
blastomeres (Fig. 4). Furthermore,
overexpression of XTcf-3 blocked activation of pSia-Luc by Xdsh.
However, coinjection of XTcf-3 mRNA and PP2A-C In this report, we show that PP2A plays a positive role in Wnt
signal transduction. Coinjection of the catalytic subunit potentiates signaling by Xdsh, as assayed by the ability of Xdsh to induce a
secondary axis or activate a Siamois-luciferase reporter.
Inhibition of endogenous PP2A-C by small t antigen blocks the ability
of Xdsh to activate Siamois, demonstrating that PP2A-C is
required for Wnt signal transduction. These findings are unexpected,
because previously published data suggested that PP2A-C might be an
inhibitor of the pathway in mammalian cells (26).
The PP2A-B' In mammalian tissue culture cells, Myc- Because PP2A had no discernable effect on We next tested the possibility that PP2A acts at the level of Tcfs,
which are necessary downstream components of Wnt signal transduction.
Tcfs function as transcriptional repressors (29, 45, 48), but they can
be converted into activators of Wnt target genes when complexed with
We acknowledge the participation of Liza
Konnikova at the initial stage of this work and for help in
sequencing. We thank Marc Mumby, David Kimelman,
Victor Shifrin, and Hans Clevers for plasmids and
Barbara Brott for critical reading of the manuscript.
*
This work was supported by National Institutes of Health
grants (to S. Y. S.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF298157.
Published, JBC Papers in Press, September 27, 2000, DOI 10.1074/jbc.C000639200
2
S. Sokol, unpublished information.
The abbreviations used are:
GSK, glycogen
synthase kinase;
PP2A, protein phosphatase-2A;
DN, dominant negative;
Smt, small t antigen;
APC, adenomatous polyposis coli;
Luc, luciferase;
X, Xenopus.
ACCELERATED PUBLICATION
A Positive Role for the PP2A Catalytic Subunit in Wnt Signal
Transduction*
,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
subunit, consistent with
the requirement of PP2A function in this pathway. Although Wnt
signaling is thought to occur via regulation of 
catenin
degradation, PP2A-C did not significantly affect 
catenin
stability. Moreover, the pathway activated by a stabilized form of

catenin was sensitive to PP2A-C and its inhibitors, suggesting
that PP2A-C acts downstream of
-catenin. Because previous work has
suggested that PP2A can act upstream of
-catenin, we propose that
PP2A regulates the Wnt pathway at multiple levels.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
(GSK-3
),1 the adenomatous
polyposis coli gene product (APC), protein phosphatase-2A (PP2A), and
-catenin (13-16). In the absence of Wnt signaling,
-catenin
within this complex is phosphorylated by GSK-3, and this leads to its
rapid degradation via the ubiquitin pathway (17). In response to Wnt
signals,
-catenin is no longer targeted for degradation and
accumulates to high levels in the cytoplasm (18). This stabilized
-catenin enters the nucleus and, complexed with transcription
factors of the Lef-1/Tcf family, promotes the transcription of target
genes (19, 20) such as Siamois (21).
-catenin complex is regulated by Wnt
signaling is not yet known. Regulation of phosphorylation is likely to
play an important role, because Dsh, Axin, APC, GSK-3, and
-catenin
are all phosphoproteins. The serine/threonine phosphatase PP2A has a
wide range of substrates and is important in many cellular processes.
It comprises a regulatory A subunit, a catalytic C subunit, and
variable regulatory B subunits, which may target the location and/or
action of the holoenzyme (22-24). Mouse embryos lacking the
PP2A-C
gene die 6.5 days post coitum, indicating
that PP2A has a critical function during early development (25). PP2A-C
was shown to bind to Axin (15), whereas regulatory subunits of the
PP2A-B' family can interact with APC (26). Also, PP2A can promote
dephosphorylation of both APC and Axin (27, 28). Overexpression of the
PP2A-B'
subunit causes a decrease in levels of
-catenin in
mammalian tissue culture cells (26). Although these observations
indicate that PP2A may regulate
-catenin degradation, the specific
role of the catalytic subunit and the function of the holoenzyme in the
Wnt pathway remain unclear.
-catenin, and it may serve to activate Tcf transcription factors.
Because PP2A has also been shown to act upstream of
-catenin, we
propose that this enzyme regulates the Wnt pathway at multiple levels.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
was subcloned into pCS2 (33) using BamHI and
EcoRI restriction sites; SV40 small t antigen was subcloned into pXT7 (31) via KpnI and BglII sites.
Xenopus PP2A-B'
cDNA was isolated in a yeast two
hybrid screen using Xdsh as a bait, as described (12). Of the 189 positive clones isolated in this screen 67 were sequenced, and 9 encoded Xenopus PP2A-B'
. The Xenopus
PP2A-B'
sequence has been deposited in GenBankTM under accession
number AF298157. A cDNA comprising the entire coding sequence of PP2A-B'
was subcloned into
pXT7HA,2 using available
restriction sites. Detailed cloning strategies are available on
request. Stabilized and wild-type forms of Myc-
-catenin, XBC26 and XBC40, (18) were a gift of David Kimelman; XTcf-3 (19) was
a gift of Hans Clevers.
, 200 or 50 pg; small t antigen, 50 pg; PP2A-C
, 1 ng; DN-GSK-3, 200 pg;
stabilized
-catenin (XBC26), 200 pg; and XTcf-3, 250 pg.
-catenin stability assays,
Myc-
-catenin RNA (XBC40; 50 pg) was injected into the two ventral
animal cells at the 4-8-cell stage, alone or in the presence of
PP2A-C
, small t antigen or DN-GSK-3
RNA. Five embryos were
harvested at stage 10.5 in 100 µl of lysis buffer (50 mM
Tris·HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 10 mM NaF, 1 mM
Na3VO4), and cell debris and yolk platelets
were removed by centrifugation at 14,000 rpm for 5 min. The supernatant
was mixed 1:1 with 2× sample loading buffer (35), and samples were
analyzed by standard SDS polyacrylamide gel electrophoresis and Western
blotting procedures as described (12). Myc antibodies were from the
9E10 hybridoma (36), and
-tubulin monoclonal antibodies were from Sigma.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
) was coinjected with mRNA for
Xdsh into ventral-vegetal blastomeres of four cell-stage embryos.
PP2A-C
did not inhibit the ability of Xdsh to induce a secondary
axis nor was it able to induce a secondary axis when expressed alone (data not shown). When low doses of Xdsh were used such that secondary axes were often only partial and formed at lower frequencies, PP2A-C
was found to increase the incidence of secondary axis formation (Fig.
1A and B).
Furthermore, a higher percentage of these axes were complete, as scored
by the presence of eyes and cement gland (see Fig. 1 and Table
I). This result shows that PP2A-C
cooperates with Xdsh in axis induction.

View larger version (136K):
[in a new window]
Fig. 1.
Effects of PP2A subunits on Xdsh
signaling. mRNAs were injected into both ventral-vegetal
blastomeres at the 8-cell stage. A, when Xdsh mRNA is
injected at a low dose (125 pg), many embryos develop normally. Some
embryos form partial secondary axes, lacking eyes and cement gland
(arrowhead). B, coinjection of PP2A-C
with
Xdsh (125 pg) leads to an increase in the proportion of embryos with
secondary axes, and many of these have eyes and cement glands.
C, Xdsh mRNA (500 pg); Xdsh induces a complete secondary
axis when expressed at high levels. D, Xdsh (500 pg) + PP2A-B'
; PP2A-B'
blocks the ability of Xdsh to induce a secondary
axis.
Compiled data for effects of PP2A-C and PP2A-B'
subunits on
secondary axis induction by Xdsh
(Fig. 2A). Together, these data
suggest that the catalytic subunit of PP2A plays a positive role in Wnt
signal transduction.

View larger version (20K):
[in a new window]
Fig. 2.
PP2A-C is required for Xdsh signaling.
DNAs for pSia-Luc or pE1b-Luc were injected alone or with mRNAs
encoding Xdsh and/or PP2A-C antagonists into the animal pole of both
ventral blastomeres at the 4-8-cell stage. Embryos were left to
develop until stage 10.5 and were then harvested, and embryo lysates
were assayed for luciferase activity. Aliquots of these samples were
analyzed by Western blotting to confirm that the level of Xdsh
expression was unaffected by PP2A subunits or inhibitors (data not
shown). A, Xdsh (125 pg) induces pSia-Luc. This is increased
3-fold by coinjection of PP2A-C
RNA. B, activation of
pSia-Luc by Xdsh (500 pg) is inhibited by Smt or by PP2A-B'
. The
activity of the control pE1b-Luc reporter is not inhibited by Smt or
PP2A-B'
. RLU, relative light units.
Subunit Is an Antagonist of Xdsh--
In addition
to Smt, regulatory B subunits of PP2A can modulate PP2A activity (40,
41). They have been proposed to target PP2A-C to specific cellular
locations and/or confer substrate specificity (24, 42, 43). Biochemical
studies of purified PP2A have shown that dissociation of the B subunit
from the core enzyme (AC) leads to increased phosphatase activity,
suggesting that B subunits can act as negative regulators of the
catalytic subunit (40, 41). A cDNA encoding the PP2A-B'
subunit
was isolated in a yeast two-hybrid screen of a Xenopus
gastrula cDNA library using Xenopus Dishevelled as a
bait. This Xenopus PP2A-B'
was highly conserved,
revealing 96% identity with human PP2A-B'
at the amino acid level
(data not shown). Coinjection of mRNA encoding the
Xenopus PP2A-B'
subunit with Xdsh mRNA blocked the ability of Xdsh mRNA to induce a secondary axis (see Fig. 1,
C and D and Table I). Furthermore, PP2A-B'
,
like Smt, inhibited activation of the pSia-Luc reporter by Xdsh (Fig.
2B) while slightly increasing activation of a control
E1b-Luc reporter. Thus, overexpression of the PP2A-B'
subunit has an
effect opposite that of the catalytic subunit. These data are
consistent with the hypothesis that the PP2A-B'
subunit acts as a
negative regulator of the catalytic subunit and further support a
requirement of PP2A in Wnt signal transduction.
-Catenin Stabilization--
In
mammalian cells, overexpression of PP2A-B'
leads to
-catenin
degradation (26), suggesting that PP2A-C may promote 
catenin stabilization. This result could provide an explanation for the positive role of PP2A in Wnt signaling. To determine the effect of
PP2A-C on the stability of
-catenin, low doses (50 pg) of RNA
encoding Myc-
-catenin were injected with PP2A-C
or Smt RNAs into
ventral animal blastomeres of Xenopus embryos at the 4-cell stage. Embryos were harvested for protein analysis at stage 10.5. PP2A-C
or Smt had no effect on the levels of Myc-
-catenin (Fig. 3A). As a positive control,
dominant negative GSK-3 RNA caused a clear increase in the levels of
-catenin in the same experiment.

View larger version (24K):
[in a new window]
Fig. 3.
PP2A acts downstream of
-catenin. A, Myc-
-catenin
mRNA was injected into ventral animal blastomeres alone
(Control) or in the presence of RNA encoding PP2A-C
, Smt,
or DN-GSK-3. Myc-
-catenin levels were assayed from embryos harvested
at stage 10.5.
-Tubulin serves as a loading control. B
and C, pSia-Luc reporter DNA was coinjected with various
mRNAs into the animal-ventral blastomeres of a 4-cell embryo.
Luciferase activity was assayed at stage 10.5. B, PP2A-C
increases the activation of pSia-Luc by XBC26. C, small t
antigen blocks the activation of pSia-Luc by XBC26. RLU,
relative light units.
-catenin levels suggested
that the potentiation of Wnt signaling by PP2A-C might occur by a
mechanism other than increasing
-catenin stability. To investigate
this possibility, we used a form of
-catenin, XBC26, which lacks the
N-terminal phosphorylation sites necessary for targeting to the
ubiquitin-mediated degradation pathway (18). Injection of PP2A-C
RNA
increased the induction of pSia-Luc by XBC26 RNA (Fig. 3B).
Conversely, Smt inhibited activation of pSia-Luc by XBC26 (Fig.
3C). Activation was also blocked by high doses of PP2A-B'
(data not shown). Thus the PP2A catalytic subunit plays a positive role
in Wnt signaling that is downstream or parallel to
-catenin stabilization.
mRNA caused a
significant increase in promoter activity (Fig. 4). This result
suggests that PP2A-C may promote the conversion of XTcf-3 from a
repressor to an activator.

View larger version (21K):
[in a new window]
Fig. 4.
XTcf-3 switches from a repressor to an
activator in the presence of PP2A-C
.
pSia-Luc reporter DNA was coinjected with various mRNAs into the
animal-ventral blastomeres of a 4-cell embryo. Luciferase activity was
assayed at stage 10.5. Neither XTcf-3 nor PP2A-C
alone significantly
activate pSia-Luc. XTcf-3 inhibits activation of pSia-Luc by Xdsh. When
both XTcf-3 and PP2A-C
are injected together the reporter is
activated.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
regulatory subunit of PP2A has been shown to bind to APC
and is a negative regulator of Wnt signaling (26). We isolated a highly
conserved Xenopus homologue of PP2A-B'
using a yeast
two-hybrid screen for proteins interacting with Xdsh. However, we were
unable to demonstrate binding of PP2A-B'
to Xdsh in embryo lysates,
suggesting that the binding may be weak or transient. Consistent with
the earlier report (26), our data show that PP2A-B'
inhibits axis
induction by Xdsh. Thus, the PP2A-B'
subunit acts in an opposite
manner to the catalytic subunit and is likely to function as an
antagonist of PP2A-C. Our in vivo experiments support
biochemical studies in which the presence of certain regulatory B
subunits was correlated with reduced activity of the enzyme (40,
41).
-catenin levels are increased
by okadaic acid, an inhibitor of PP2A-C (26). In our experiments we did
not observe a significant change in the stability of
-catenin in
response to PP2A-C or Smt, whereas
-catenin was clearly stabilized
by dominant negative GSK-3 (Fig. 3A). The assay we used may
not be sufficiently sensitive. It is also possible that PP2A may behave
differently in mammalian and Xenopus systems. Such
differences in the Wnt pathway have been previously documented for APC,
a potential PP2A substrate that inhibits Wnt signaling in mouse cells
(46) but activates the same pathway in Xenopus embryos
(47).
-catenin stability in our
experiments, we tested whether this phosphatase functions downstream of
-catenin. We found that target gene activation by stabilized
-catenin is potentiated by PP2A-C and blocked by Smt. Therefore,
PP2A can regulate the pathway via a mechanism independent of

catenin stabilization.
-catenin (19, 20, 49). In Xenopus, overexpression of
XTcf-3 represses endogenous Wnt signaling in the dorsal marginal zone
(45). We also found that XTcf-3 suppressed signaling by Xdsh or
-catenin (Fig. 4 and data not shown). However, upon coinjection of
XTcf-3 and PP2A-C, a Siamois reporter construct was markedly
activated (Fig. 4). This result suggests that PP2A-C can promote the
conversion of XTcf-3 from a repressor to an activator. We propose that
endogenous PP2A-C levels are insufficient for activation of
overexpressed XTcf-3, which therefore behaves as a repressor of Wnt
signaling. However, when PP2A-C is provided in excess, XTcf-3 now
behaves as a transcriptional activator. XTcf-3 is known to bind
corepressor molecules such as C-terminal binding protein (45) or
Groucho (50), and signaling by PP2A-C might relieve this repression.
Although XTcf-3 may be a direct substrate for PP2A, it is also possible
that one of the many pathways involving PP2A could integrate with Wnt
signaling downstream of
-catenin. These possibilities remain to be
tested by future studies.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
To whom correspondence should be addressed: Dept. of Microbiology
and Molecular Genetics, Harvard Medical School, Molecular Medicine
Unit, RW 663, Beth Israel Deaconess Medical Center, East Campus, 330 Brookline Ave., Boston, MA 02215. Tel.: 617-667-3746; Fax:
617-667-2913; E-mail: mratclif@caregroup.harvard.edu.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Cadigan, K. M.,
and Nusse, R.
(1997)
Genes Dev.
11,
3286-3305
2.
Moon, R. T.,
Brown, J. D.,
and Torres, M.
(1997)
Trends Genet.
13,
157-162
3.
Nusse, R.,
and Varmus, H. E.
(1992)
Cell
69,
1073-1087
4.
Sokol, S.,
Christian, J. L.,
Moon, R. T.,
and Melton, D. A.
(1991)
Cell
67,
741-752
5.
Heasman, J.,
Crawford, A.,
Goldstone, K.,
Garner-Hamrick, P.,
Gumbiner, B.,
McCrea, P.,
Kintner, C.,
Yoshida Noro, C.,
and Wylie, C.
(1994)
Cell
79,
791-803
6.
Zeng, L.,
Fagotto, F.,
Zhang, T.,
Hsu, W.,
Vasicek, T. J.,
Perry, W. L., III,
Lee, J. J.,
Tilghman, S. M.,
Gumbiner, B. M.,
and Costantini, F.
(1997)
Cell
90,
181-192
7.
He, X.,
Saint-Jeannet, J.-P.,
Wang, Y.,
Nathans, J.,
Dawid, I.,
and Varmus, H.
(1997)
Science
275,
1652-1654
8.
Yang-Snyder, J.,
Miller, J. R.,
Brown, J. D.,
Lai, C.-J.,
and Moon, R. T.
(1996)
Curr. Biol.
6,
1302-1306
9.
Smalley, M. J.,
Sara, E.,
Paterson, H.,
Naylor, S.,
Cook, D.,
Jayatilake, H.,
Fryer, L. G.,
Hutchinson, L.,
Fry, M. J.,
and Dale, T. C.
(1999)
EMBO J.
18,
2823-2835
10.
Kishida, S.,
Yamamoto, H.,
Hino, S.,
Ikeda, S.,
Kishida, M.,
and Kikuchi, A.
(1999)
Mol. Cell. Biol.
19,
4414-4422
11.
Li, L.,
Yuan, H.,
Weaver, C. D.,
Mao, J.,
Farr, G. H., III,
Sussman, D. J.,
Jonkers, J.,
Kimelman, D.,
and Wu, D.
(1999)
EMBO J.
18,
4233-4240
12.
Itoh, K.,
Antipova, A.,
Ratcliffe, M. J.,
and Sokol, S.
(2000)
Mol. Cell. Biol.
20,
2228-2238
13.
Itoh, K.,
Krupnik, V. E.,
and Sokol, S. Y.
(1998)
Curr. Biol.
8,
591-594
14.
Ikeda, S.,
Kishida, S.,
Yamamoto, H.,
Murai, H.,
Koyama, S.,
and Kikuchi, A.
(1998)
EMBO J.
17,
1371-1384
15.
Hsu, W.,
Zeng, L.,
and Costantini, F.
(1999)
J. Biol. Chem.
274,
3439-3445
16.
Nakamura, T.,
Hamada, F.,
Ishidate, T.,
Anai, K.,
Kawahara, K.,
Toyoshima, K.,
and Akiyama, T.
(1998)
Genes Cells
3,
395-403
17.
Aberle, H.,
Bauer, A.,
Stappert, J.,
Kispert, A.,
and Kemler, R.
(1997)
EMBO J.
16,
3797-3804
18.
Yost, C.,
Torres, M.,
Miller, J. R.,
Huang, E.,
Kimelman, D.,
and Moon, R. T.
(1996)
Genes Dev.
10,
1443-1454
19.
Molenaar, M.,
van de Wetering, M.,
Oosterwegel, M.,
Peterson-Maduro, J.,
Godsave, S.,
Korinek, V.,
Roose, J.,
Destrée, O.,
and Clevers, H.
(1996)
Cell
86,
391-399
20.
Behrens, J.,
von Kries, J. P.,
Kühl, M.,
Bruhn, L.,
Wedlich, D.,
Grosschedl, R.,
and Birchmeier, W.
(1996)
Nature
382,
638-642
21.
Lemaire, P.,
Garrett, N.,
and Gurdon, J. B.
(1995)
Cell
81,
85-94
22.
Millward, T. A.,
Zolnierowicz, S.,
and Hemmings, B. A.
(1999)
Trends Biochem. Sci.
24,
186-191
23.
Mumby, M. C.,
and Walter, G.
(1993)
Physiol. Rev.
73,
673-699
24.
Shenolikar, S.
(1994)
Annu. Rev. Cell Biol.
10,
55-86
25.
Götz, J.,
Probst, A.,
Ehler, E.,
Hemmings, B.,
and Kues, W.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
12370-12375
26.
Seeling, J. M.,
Miller, J. R.,
Gil, R.,
Moon, R. T.,
White, R.,
and Virshup, D. M.
(1999)
Science
283,
2089-2091
27.
Ikeda, S.,
Kishida, M.,
Matsuura, Y.,
Usui, H.,
and Kikuchi, A.
(2000)
Oncogene
19,
537-545
28.
Willert, K.,
Shibamoto, S.,
and Nusse, R.
(1999)
Genes Dev.
13,
1768-1773
29.
Fan, M. J.,
Gruning, W.,
Walz, G.,
and Sokol, S. Y.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
5626-5631
30.
Wu, L.,
Rosser, D. S.,
Schmidt, M. C.,
and Berk, A.
(1987)
Nature
326,
512-515
31.
Dominguez, I.,
Itoh, K.,
and Sokol, S. Y.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
8498-8502
32.
Green, D. D.,
Yang, S. I.,
and Mumby, M. C.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
4880-4884
33.
Turner, D. L.,
and Weintraub, H.
(1994)
Genes Dev.
8,
1434-1447
34.
Fan, M. J.,
and Sokol, S. Y.
(1997)
Development
124,
2581-2589
35.
Laemmli, U. K.
(1970)
Nature
227,
680-685
36.
Evan, G. I.,
Lewis, G. K.,
Ramsay, G.,
and Bishop, J. M.
(1985)
Mol. Cell. Biol.
5,
3610-3616
37.
Sokol, S. Y.,
Klingensmith, J.,
Perrimon, N.,
and Itoh, K.
(1995)
Development
121,
1637-1647
38.
Rothbacher, U.,
Laurent, M. N.,
Blitz, I. L.,
Watabe, T.,
Marsh, J. L.,
and Cho, K. W. Y.
(1995)
Dev. Biol.
170,
717-721
39.
Yang, S. I.,
Lickteig, R. L.,
Estes, R.,
Rundell, K.,
Walter, G.,
and Mumby, M. C.
(1991)
Mol. Cell. Biol.
11,
1988-1995
40.
Kamibayashi, C.,
Estes, R.,
Slaughter, C.,
and Mumby, M. C.
(1991)
J. Biol. Chem.
266,
13251-13260
41.
Kamibayashi, C.,
Estes, R.,
Lickteig, R. L.,
Yang, S. I.,
Craft, C.,
and Mumby, M. C.
(1994)
J. Biol. Chem.
269,
20139-20148
42.
Sontag, E.,
Nunbhakdi-Craig, V.,
Bloom, G. S.,
and Mumby, M. C.
(1995)
J. Cell Biol.
128,
1131-1144
43.
McCright, B.,
Rivers, A. M.,
Audlin, S.,
and Virshup, D. M.
(1996)
J. Biol. Chem.
271,
22081-22089
44.
Ishitani, T.,
Ninomiya-Tsuji, J.,
Nagai, S.,
Nishita, M.,
Meneghini, M.,
Barker, N.,
Waterman, M.,
Bowerman, B.,
Clevers, H.,
Shibuya, H.,
and Matsumoto, K.
(1999)
Nature
399,
798-802
45.
Brannon, M.,
Brown, J. D.,
Bates, R.,
Kimelman, D.,
and Moon, R. T.
(1999)
Development
126,
3159-3170
46.
Munemitsu, S.,
Albert, I.,
Souza, B.,
Rubinfeld, B.,
and Polakis, P.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
3046-3050
47.
Vleminckx, K.,
Wong, E.,
Guger, K.,
Rubinfeld, B.,
Polakis, P.,
and Gumbiner, B. M.
(1997)
J. Cell Biol.
136,
411-420
48.
Brannon, M.,
Gomperts, M.,
Sumoy, L.,
Moon, R. T.,
and Kimelman, D.
(1997)
Genes Dev.
11,
2359-2370
49.
Brunner, E.,
Peter, O.,
Schweizer, L.,
and Basler, K.
(1997)
Nature
385,
829-833
50.
Roose, J.,
Molenaar, M.,
Peterson, J.,
Hurenkamp, J.,
Brantjes, H.,
Moerer, P.,
van de Wetering, M.,
Destrée, O.,
and Clevers, H.
(1998)
Nature
395,
608-612
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. M. Stiening, J. B. Hoying, M. B. Abdallah, A. M. Hoying, R. Pandey, K. Greer, and R. J. Collier The Effects of Endocrine and Mechanical Stimulation on Stage I Lactogenesis in Bovine Mammary Epithelial Cells J Dairy Sci, March 1, 2008; 91(3): 1053 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tran, F. Hamada, T. Schwarz-Romond, and M. Bienz Trabid, a new positive regulator of Wnt-induced transcription with preference for binding and cleaving K63-linked ubiquitin chains Genes & Dev., February 15, 2008; 22(4): 528 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bhasin, S. R. Cunha, M. Mudannayake, M. S. Gigena, T. B. Rogers, and P. J. Mohler Molecular basis for PP2A regulatory subunit B56{alpha} targeting in cardiomyocytes Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H109 - H119. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Nazarenko, R. Schafer, and C. Sers Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells J. Cell Sci., April 15, 2007; 120(8): 1393 - 1404. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Miyabayashi, J.-L. Teo, M. Yamamoto, M. McMillan, C. Nguyen, and M. Kahn Wnt/beta-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency PNAS, March 27, 2007; 104(13): 5668 - 5673. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Bos, S. H. Diks, J. C.H. Hardwick, K. V. Walburg, M. P. Peppelenbosch, and D. J. Richel Protein phosphatase 2A is required for mesalazine-dependent inhibition of Wnt/{beta}-catenin pathway activity Carcinogenesis, December 1, 2006; 27(12): 2371 - 2382. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Van Kanegan, D. G. Adams, B. E. Wadzinski, and S. Strack Distinct Protein Phosphatase 2A Heterotrimers Modulate Growth Factor Signaling to Extracellular Signal-regulated Kinases and Akt J. Biol. Chem., October 28, 2005; 280(43): 36029 - 36036. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Wallingford and R. Habas The developmental biology of Dishevelled: an enigmatic protein governing cell fate and cell polarity Development, October 15, 2005; 132(20): 4421 - 4436. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Uren, S. Fallen, H. Yuan, A. Usubutun, T. Kucukali, R. Schlegel, and J. A. Toretsky Activation of the Canonical Wnt Pathway during Genital Keratinocyte Transformation: A Model for Cervical Cancer Progression Cancer Res., July 15, 2005; 65(14): 6199 - 6206. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Salahshor and J R Woodgett The links between axin and carcinogenesis J. Clin. Pathol., March 1, 2005; 58(3): 225 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Swiatek, I-C. Tsai, L. Klimowski, A. Pepler, J. Barnette, H. J. Yost, and D. M. Virshup Regulation of Casein Kinase I{epsilon} Activity by Wnt Signaling J. Biol. Chem., March 26, 2004; 279(13): 13011 - 13017. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Matsubayashi, S. Sese, J.-S. Lee, T. Shirakawa, T. Iwatsubo, T. Tomita, and S.-i. Yanagawa Biochemical Characterization of the Drosophila Wingless Signaling Pathway Based on RNA Interference Mol. Cell. Biol., March 1, 2004; 24(5): 2012 - 2024. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Saez, J. Rosenfeld, A. Livolsi, P. Olson, E. Lombardo, M. Nelson, E. Banayo, R. D. Cardiff, J. C. Izpisua-Belmonte, and R. M. Evans PPAR{gamma} signaling exacerbates mammary gland tumor development Genes & Dev., March 1, 2004; 18(5): 528 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bajpai, K. Makhijani, P. R. Rao, and L. S. Shashidhara Drosophila Twins regulates Armadillo levels in response to Wg/Wnt signal Development, March 1, 2004; 131(5): 1007 - 1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yang, J. Wu, C. Tan, and P. S. Klein PP2A:B56{epsilon} is required for Wnt/{beta}-catenin signaling during embryonic development Development, December 1, 2003; 130(23): 5569 - 5578. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xing, W. K. Clements, D. Kimelman, and W. Xu Crystal structure of a {beta}-catenin/Axin complex suggests a mechanism for the {beta}-catenin destruction complex Genes & Dev., November 15, 2003; 17(22): 2753 - 2764. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hannus, F. Feiguin, C.-P. Heisenberg, and S. Eaton Planar cell polarization requires Widerborst, a B' regulatory subunit of protein phosphatase 2A Development, March 9, 2003; 129(14): 3493 - 3503. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Everett, C. Kamibayashi, and D. L. Brautigan Transgenic expression of protein phosphatase 2A regulatory subunit B56gamma disrupts distal lung differentiation Am J Physiol Lung Cell Mol Physiol, June 1, 2002; 282(6): L1266 - L1271. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-H. Gao, J. M. Seeling, V. Hill, A. Yochum, and D. M. Virshup Casein kinase I phosphorylates and destabilizes the beta -catenin degradation complex PNAS, January 24, 2002; (2002) 32468199. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. van de Water, M. van de Wetering, J. Joore, J. Esseling, R. Bink, H. Clevers, and D. Zivkovic Ectopic Wnt signal determines the eyeless phenotype of zebrafish masterblind mutant Development, October 15, 2001; 128(20): 3877 - 3888. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yamamoto, T. Hinoi, T. Michiue, A. Fukui, H. Usui, V. Janssens, C. Van Hoof, J. Goris, M. Asashima, and A. Kikuchi Inhibition of the Wnt Signaling Pathway by the PR61 Subunit of Protein Phosphatase 2A J. Biol. Chem., July 13, 2001; 276(29): 26875 - 26882. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-H. Gao, J. M. Seeling, V. Hill, A. Yochum, and D. M. Virshup Casein kinase I phosphorylates and destabilizes the beta -catenin degradation complex PNAS, February 5, 2002; 99(3): 1182 - 1187. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||